Publications by authors named "T Wehler"

Claim this Profile
T
Treatment outcome of NSCLC patients with BRAF mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany.
C Kropf-Sanchen, A Rasokat, P Christopoulos, C Wenzel, T Wehler

ESMO Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.
Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna R Minchom, Thomas Wehler

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis.
Sandra Michaela Ihne-Schubert, Caroline Morbach, Vladimir Cejka, Maximilian Johannes Steinhardt, Aikaterini Papagianni, Thomas Wehler

Clin Res Cardiol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study, VARGADO.
Christian Grohé, Thomas Wehler, Tobias Dechow, Sven Henschke, Wolfgang Schuette

Transl Lung Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in lung cancer survivors treated with tyrosine-kinase inhibitors (TKI): results from the multi-centre cross-sectional German study LARIS.
Nicola Riccetti, Maria Blettner, Katherine Taylor, Beatrice Wehler, Bernhard Gohrbandt, Thomas Wehler

J Cancer Res Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis